Literature DB >> 7273808

Dopamine administration in oliguria and oliguric renal failure.

S Parker, G C Carlon, M Isaacs, W S Howland, R C Kahn.   

Abstract

Oliguric renal failure significanlty worsens the prognosis of many critical illnesses, particularly in patients with respiratory failure. In 52 patients, a continuous infusion of dopamine, 1.5-2.5 micrograms/kg . min, was administered when creatine clearance (Ccr) fell below 40 ml/min and urinary output was less than 1 ml/kg . h despite normal intravascular volume. In 18 patients, a continuous infusion of furosemide (3-5 mg/kg . day) was also administered. Daily, two 3-h collections of urine and blood specimens were obtained to determine Ccr, osmolar clearance (Cosm), free water clearance (CH2O) and excreted fraction of filtered sodium (FENa); one collection was made during dopamine infusion and one while the infusion was suspended. Cardiac output and pulmonary venous admixture were also measured. The authors obtained 199 urine collections in 52 patients; considering the aggregate patient pouplation, urinary output increased by 42.3% (30.2 +/- 3.45 (SEM) ml/h), on dopamine infusion. Cosm, FENa, and Ccr were also higher on dopamine. CH2O and hemodynamic variables were not altered by dopamine infusion. When patients were startified on the basis of mechanical ventilatory support, Ccr and furosemide administration, dopamine infusion essentially caused the same changes in the variables studied as described for the aggregate patient population. Diuresis and sodium excretion increased significantly on dopamine even in those patients receiving furosemide infusion. The authors conclude that fluid and osmolar load can be eliminated more effectively in critically ill patients with continuous infusion of 1.5-2.5 micrograms/kg . min of dopamine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7273808     DOI: 10.1097/00003246-198109000-00002

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  8 in total

Review 1.  Can the use of low-dose dopamine for treatment of acute renal failure be justified?

Authors:  C J Burton; C R Tomson
Journal:  Postgrad Med J       Date:  1999-05       Impact factor: 2.401

2.  Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines.

Authors:  T Lherm; G Troché; M Rossignol; P Bordes; J F Zazzo
Journal:  Intensive Care Med       Date:  1996-03       Impact factor: 17.440

Review 3.  Acute renal failure in the intensive care unit. Part 2.

Authors:  H L Corwin; J V Bonventre
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

Review 4.  Pathophysiology and prevention of acute renal failure: the role of the anaesthetist.

Authors:  R J Byrick; D K Rose
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

5.  Pharmacokinetics of pancuronium in patients undergoing coronary artery surgery with and without low dose dopamine.

Authors:  J M Wierda; P J van der Starre; A H Scaf; W D Kloppenburg; J H Proost; S Agoston
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 6.  The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.

Authors:  A Bodenham; M P Shelly; G R Park
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

7.  Effect of low-dose dopamine on the pharmacokinetics of tobramycin in dogs.

Authors:  M G Kirby; J F Dasta; D K Armstrong; R Tallman
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

8.  The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence.

Authors: 
Journal:  Crit Care       Date:  1997       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.